GUY J. JORDAN, PH.D.

Corporate Board Profile

Tech Score: 0/100

Orthofix Medical Inc.

Filing Date	Source Excerpt
2014-04-30	Dr. Jordan, 65, became a director of Orthofix in 2004. The Board believes that Dr. Jordan’s experience as an executive and board member of several medical device companies, as well as his academic background, brings valuable insight to the Board. He provides relevant knowledge and understanding of public company governance and compensation issues. Dr. Jordan currently serves as Chair of the Compensation Committee and is a member of the Compliance Committee.
2015-04-30	Dr. Jordan, 66, became a director of Orthofix in 2004. Most recently, from 1996 to 2002, Dr. Jordan served as a Group President at CR Bard, Inc., a medical device company, where he had strategic and operating responsibilities for Bard's global oncology business and functional responsibility for all of Bard's research and development. Dr. Jordan earned a Ph.D. in organic chemistry from Georgetown University as well as an MBA from Fairleigh Dickinson University. He also currently serves on the board of Tangent Medical, Inc. a private health care company.

Filing Date

Source Excerpt

2014-04-30

Dr. Jordan, 65, became a director of Orthofix in 2004. The Board believes that Dr. Jordan’s experience as an executive and board member of several medical device companies, as well as his academic background, brings valuable insight to the Board. He provides relevant knowledge and understanding of public company governance and compensation issues. Dr. Jordan currently serves as Chair of the Compensation Committee and is a member of the Compliance Committee.

2015-04-30

Dr. Jordan, 66, became a director of Orthofix in 2004. Most recently, from 1996 to 2002, Dr. Jordan served as a Group President at CR Bard, Inc., a medical device company, where he had strategic and operating responsibilities for Bard's global oncology business and functional responsibility for all of Bard's research and development. Dr. Jordan earned a Ph.D. in organic chemistry from Georgetown University as well as an MBA from Fairleigh Dickinson University. He also currently serves on the board of Tangent Medical, Inc. a private health care company.

Data sourced from SEC filings. Last updated: 2026-02-03